Skip to main content
Clinical Trials/ISRCTN75092026
ISRCTN75092026
Completed
未知

A randomised controlled trial of a low energy diet treatment compared with usual care for weight management in primary care

niversity of Oxford0 sites270 target enrollmentMay 19, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Obesity in adults
Sponsor
niversity of Oxford
Enrollment
270
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28780559 protocol 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30257983 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30801983 results (added 18/12/2019) 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32295605 results (added 17/04/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33827433/ exploratory results (added 09/04/2021) 2020 Results article in https://doi.org/10.1371/journal.pone.0238645 descriptive qualitative study (added 14/06/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37019430/ Secondary analysis (added 22/09/2023)

Registry
who.int
Start Date
May 19, 2015
End Date
January 1, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participant is willing and able to give informed consent for participation in the study
  • 2\. Male or female, 18 years and older.
  • 3\. Body Mass Index \=30 kg/m2
  • 4\. Likely to benefit from weight loss in the GP’s opinion

Exclusion Criteria

  • Eclusion criteria as of 15/12/2016:
  • 1\. Unable to understand English
  • 2\. Currently or recently (within 3 months of study entry) attended a weight management programme, currently participating in another weight loss study
  • 3\. Had bariatric surgery, or scheduled to have bariatric surgery
  • 4\. Breastfeeding, pregnant or planning to become pregnant during the course of the study.
  • 5\. Receiving insulin therapy
  • 6\. Heart attack or stroke within the last 3 months,
  • 7\. Heart failure of grade II New York Heart Association and more severe,
  • 8\. Angina, arrhythmia including atrial fibrillation or prolonged QT syndrome.
  • 9\. Taking MAOI medication

Outcomes

Primary Outcomes

Not specified

Similar Trials